米那普明、氟伏沙明和帕罗西汀对抑郁症的不同作用，尤其是在性别方面。 - Suppr

Suppr

超能文献

Differential effects of milnacipran, fluvoxamine and paroxetine for depression, especially in gender.

作者信息

Morishita Shigeru, Arita Seizaburo

机构信息

Department of Psychiatry, Kawasaki Medical School, 577 Matsushima, Kurashiki-city, 701-0192 Okayama, Japan.

出版信息

Eur Psychiatry. 2003 Dec;18(8):418-20. doi: 10.1016/j.eurpsy.2003.05.002.

DOI:10.1016/j.eurpsy.2003.05.002

PMID:14680720

Abstract

摘要

相似文献

Differential effects of milnacipran, fluvoxamine and paroxetine for depression, especially in gender.米那普明、氟伏沙明和帕罗西汀对抑郁症的不同作用，尤其是在性别方面。

Eur Psychiatry. 2003 Dec;18(8):418-20. doi: 10.1016/j.eurpsy.2003.05.002.

A comparative study of milnacipran and paroxetine in outpatients with major depression.米那普明与帕罗西汀治疗门诊重性抑郁症患者的对照研究。

J Affect Disord. 2004 Dec;83(2-3):233-6. doi: 10.1016/j.jad.2004.07.002.

Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients.帕罗西汀或米那普明对抑郁症患者血清脑源性神经营养因子的影响。

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1034-7. doi: 10.1016/j.pnpbp.2007.03.001. Epub 2007 Mar 7.

Post-treatment emergent adverse events in depressed patients following treatment with milnacipran and paroxetine.米那普明和帕罗西汀治疗后抑郁症患者出现的治疗后新发不良事件。

Hum Psychopharmacol. 2004 Dec;19(8):585-6. doi: 10.1002/hup.644.

Differential period of onset of action of fluvoxamine, paroxetine and milnacipran for depression.氟伏沙明、帕罗西汀和米那普明治疗抑郁症的起效差异期。

Hum Psychopharmacol. 2003 Aug;18(6):479-82. doi: 10.1002/hup.508.

Differential effects of milnacipran, fluvoxamine and paroxetine for inhibited and agitated depression.米那普明、氟伏沙明和帕罗西汀对抑制性抑郁和激越性抑郁的不同作用。

Eur Psychiatry. 2004 Nov;19(7):450-1. doi: 10.1016/j.eurpsy.2004.07.002.

Differential effects of fluvoxamine, paroxetine and milnacipran for depression, especially with regard to age.氟伏沙明、帕罗西汀和米那普明对抑郁症的不同影响，尤其是在年龄方面。

Hum Psychopharmacol. 2004 Aug;19(6):405-8. doi: 10.1002/hup.608.

Double-blind study of the efficacy and safety of milnacipran and imipramine in elderly patients with major depressive episode.米那普明和丙咪嗪治疗老年重度抑郁发作患者疗效及安全性的双盲研究。

Acta Psychiatr Scand. 1998 Feb;97(2):157-65. doi: 10.1111/j.1600-0447.1998.tb09980.x.

Effects of milnacipran and paroxetine on overactive bladder due to neurologic diseases: a urodynamic assessment.米那普明和帕罗西汀对神经疾病所致膀胱过度活动症的影响：一项尿动力学评估

Urol Int. 2008;81(3):335-9. doi: 10.1159/000151415. Epub 2008 Oct 16.

A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder.在伴有抑郁障碍的情况下，从氟伏沙明交叉滴定转换为帕罗西汀时出现不良反应的病例，同时伴有血浆氟伏沙明水平升高。

World J Biol Psychiatry. 2009;10(4 Pt 2):620-2. doi: 10.1080/15622970802118349.

引用本文的文献

Uncovering antidepressant prescription patterns: a three-year analysis of outpatient trends.揭示抗抑郁药处方模式：对门诊趋势的三年分析

BMC Psychiatry. 2025 Feb 3;25(1):90. doi: 10.1186/s12888-025-06521-z.

Sexually Dimorphic Effects of Neuromodulatory Drugs on Normal and Stress-Induced Social Interaction in Rats.神经调节药物对大鼠正常及应激诱导社交互动的性别差异效应。

Brain Sci. 2023 Sep 27;13(10):1378. doi: 10.3390/brainsci13101378.

Study of Sex Differences in Duloxetine Efficacy for Depression in Transgenic Mouse Models.转基因小鼠模型中度洛西汀治疗抑郁症疗效的性别差异研究

Front Cell Neurosci. 2017 Oct 31;11:344. doi: 10.3389/fncel.2017.00344. eCollection 2017.

Does early improvement in depressive symptoms predict subsequent remission in patients with depression who are treated with duloxetine?对于接受度洛西汀治疗的抑郁症患者，抑郁症状的早期改善是否能预测其随后的缓解？

Neuropsychiatr Dis Treat. 2016 May 23;12:1269-73. doi: 10.2147/NDT.S103432. eCollection 2016.

Sex differences in the prediction of the effectiveness of paroxetine for patients with major depressive disorder identified using a receiver operating characteristic curve analysis for early response.基于早期反应的受试者工作特征曲线分析识别的用于预测重度抑郁症患者帕罗西汀疗效的性别差异。

Neuropsychiatr Dis Treat. 2014 Apr 8;10:599-606. doi: 10.2147/NDT.S57189. eCollection 2014.

Differential clinical effects of fluvoxamine by the effect of age in Japanese female major depressive patients.氟伏沙明对日本女性重性抑郁患者年龄影响的临床疗效差异。

Neuropsychiatr Dis Treat. 2009;5:151-5. doi: 10.2147/ndt.s4918. Epub 2009 Apr 8.

Japanese experience with milnacipran, the first serotonin and norepinephrine reuptake inhibitor in Japan.日本对米那普仑（日本首个 5-羟色胺和去甲肾上腺素再摄取抑制剂）的应用经验。

Neuropsychiatr Dis Treat. 2007 Feb;3(1):41-58. doi: 10.2147/nedt.2007.3.1.41.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验